November 6, 2017—BTG International advised that the Centers for Medicare & Medicaid Services published the final fee schedule for new category I CPT codes for the company's Varithena procedures. The codes become effective on January 1, 2018.
The fee schedule details payments for conducting Varithena treatments in the physician office setting of $1,624.30 for a single vein and $1,697.02 for multiple veins. The new CPT codes define Medicare payment rates and enable automatic and electronic processing of claims. This will provide physicians in the United States with additional predictability of payments and streamlining of the reimbursement process, stated BTG.
advertisement
Sponsored by EKOS Corporation
Related Articles
Designing a Versatile Procedural Environment for a Rapidly Changing Interventional Field
A dyad perspective on building an advanced endovascular suite.
With Barry T. Katzen, MD
DVT: Access Decisions for Interventions
Assessing the advantages and disadvantages of venous access options is crucial for safe and successful DVT intervention.
By John A. Kaufman, MD, MS, FSIR, FAHA, FCIRSE, EBIR
Top 5 Articles From October 2017
Ensuring a Good Death: Pain Management and Palliative Procedures in the Oncology Patient
Examining the role of the interventional radiologist in providing end-of-life care.
By Joshua D. Kuban, MD; and Alda Tam, MD
Treating Peripheral Artery Disease in the Popliteal Artery: DA + DCB Versus DCB Alone
By Konstantinos Stavroulakis, MD
Locoregional Management Pathways for Liver Cancer
A practical approach to treating tumors in the liver caused by primary liver cancer, colorectal cancer, and neuroendocrine tumors.
By Martin Edwards, MD; and Siddharth A. Padia, MD
The Interventional Oncology Clinic: Introduction to the IO Clinical Care Model
Assessing interventional oncology patients in an outpatient clinic setting is essential for providing longitudinal and optimal care.
By Eric A. Wang, MD; Mendi D. Mullis, MBA; and Megan E. Kanable, MHA
Current Considerations on Real-World Evidence Use in FDA Regulatory Submissions
Examples and decision making from the Center for Devices and Radiological Health’s Peripheral Interventional Devices Branch.
By Eleni Whatley and Misti Malone
Top 5 from CIToday's Current Issue
2019 CMS Reimbursement and Your Ambulatory Strategy
As trends in health care continue to move toward ambulatory surgery centers, will you be ready to take advantage of the benefits they can offer?
With Tony Lafata; Marc Toth, CMAA; and Jacob Turmell, DNP, RN, NP-C, ACNS-BC, CCRN-CMC
Beyond Radial: Ulnar, Snuffbox, and Palmar Branch Access
A review of the limitations of transradial access and the benefits and challenges of alternative approaches for cardiac catheterization.
By Karim M. Al-Azizi, MD; and Amir S. Lotfi, MD
The Next Wave of Mechanical Circulatory Support Devices
Next-generation mechanical circulatory support devices in different phases of development and clinical use are anticipated to improve outcomes and quality of life in patients with advanced heart failure.
By Carlo R. Bartoli, MD, PhD; and Robert D. Dowling, MD, PhD (Hon)
Radial Access Best Practices in 2019
An update on procedural considerations for transradial artery access based on the most recent data.
